All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

MATCH cohort provides regulatory-ready external control framework for MSUD gene therapy trials

By

Kevin A. Strauss1,2,3 Send email to [email protected]

11d ago· 29 min readenInsight

Summary

This article presents the MSUD Age-matched Standard Treatment Cohort (MATCH), a prospective natural history study of 11 infants with classic maple syrup urine disease (MSUD) followed from neonatal diagnosis to liver transplantation. Designed as a regulatory-ready external control for gene therapy trials, MATCH aligns with FDA guidance and ICH E9(R1) standards, applying prespecified eligibility criteria, fixed visit cadence, adjudicated outcomes, and explicit handling of intercurrent events. The authors demonstrate through Monte Carlo simulations how protocolized natural history data can serve as quantitative evidence supporting ethically defensible single-arm trials in rare diseases where randomized controlled trials are infeasible.

Source

bskyMATCH cohort provides regulatory-ready external control framework for MSUD gene therapy trialscell.com

Key quotes

· 3 pulled
Maple syrup urine disease (MSUD) is a life-threatening metabolic disorder for which randomized trials are infeasible.
MATCH applies prespecified eligibility criteria, fixed visit cadence, adjudicated outcomes, and explicit handling of intercurrent events.
The authors demonstrate how protocolized data can serve as quantitative evidence supporting ethically defensible single-arm trials.
Snippet from the RSS feed
Brigatti et al. develop MATCH, a prospective natural history cohort designed as a regulatory-ready external control for gene therapy trials in maple syrup urine disease. Using prespecified estimands and Monte Carlo simulations, the authors demonstrate how

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.